Scott Schliebner

Scott Schliebner is an experienced leader in the biopharmaceutical and contract research organization sectors, currently serving as Vice President and Global Head of Drug Development Consulting at Novotech since April 2024. With a robust background in strategic leadership, Scott has held key positions including Chief Commercial Officer for early-stage biopharma service providers and Senior Vice President at TFS HealthScience, where Scott oversaw clinical development services and contributed to corporate strategy and due diligence for acquisitions. Throughout Scott's career, contributions include establishing multiple business units and centers of excellence at PRA Health Sciences, focusing on rare diseases, oncology, and advanced therapeutics. Educational credentials include a Master of Public Health from the University of Utah School of Medicine, a Bachelor of Science in Psychology from the University of Colorado Denver, and leadership training through Leadership Tomorrow.